Pfizer (PFE) Income from Continuing Operations (2009 - 2026)
Pfizer's Income from Continuing Operations came in at -$246 million for Q2 2026, compared with $2.9 billion a year earlier.
Powered by 
Analysis
Pfizer (PFE) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 28, 2026, Pfizer reported Income from Continuing Operations of $4.37 billion, down 59.4% year-over-year; for FY2025, it came in at $7.79 billion, down 3.3% from FY2024.
- Income from Continuing Operations carries a five-year compound annual growth rate of 3.2% (FY2020 to FY2025).
- Going back by year, Income from Continuing Operations was $8.05 billion in FY2024 (+270.7%), $2.17 billion in FY2023 (-93.1%), $31.4 billion in FY2022 (+39.8%) and $22.46 billion in FY2021 (+236.9%).
- The five-year range for quarterly Income from Continuing Operations is -$3.34 billion (Q4 2023) to $9.88 billion (Q2 2022).
- The fastest year-over-year change in Income from Continuing Operations over five years came in Q3 2021 (growth of 791.1%), and the weakest in Q2 2024 (a decline of 98.7%).
- Business Quant data shows PFE's Income from Continuing Operations at $2.71 billion (Q1 2026), -$1.64 billion (Q4 2025) and $3.55 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 3.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -246.00 Mn |
| Mar 29, 2026 | 2.71 Bn |
| Dec 31, 2025 | -1.64 Bn |
| Sep 28, 2025 | 3.55 Bn |
| Jun 29, 2025 | 2.90 Bn |
| Mar 30, 2025 | 2.97 Bn |
| Dec 31, 2024 | 411.00 Mn |
| Sep 29, 2024 | 4.48 Bn |
| Jun 30, 2024 | 31.00 Mn |
| Mar 31, 2024 | 3.13 Bn |
| Dec 31, 2023 | -3.34 Bn |
| Jul 2, 2023 | 2.34 Bn |
| Apr 2, 2023 | 5.56 Bn |
| Dec 31, 2022 | 5.00 Bn |
| Sep 30, 2022 | -24.66 Bn |
| Jul 3, 2022 | 9.88 Bn |
| Apr 3, 2022 | 7.88 Bn |
| Dec 31, 2021 | 3.58 Bn |
| Oct 3, 2021 | 8.17 Bn |
| Jul 4, 2021 | 5.83 Bn |
API Access
Pfizer Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();